Search clinical trials for: GlucagonLikePeptide-1 (7-36)

Total 351 results

Mette Zander
Hvidovre University Hospital

Completed

Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults

Coronary Microvascular Dysfunction

Denmark
Papworth Hospital NHS Foundation Trust

Completed

Human Vasodilatory Effect of GLP-1

Angina, Stable | Type2 Diabetes | Coronary Stenosis
Jeppe Skov
Novo Nordisk A/S

Completed

GLP-1: Acute Effects on Kidney Function in Healthy Men

Kidney Functional

Denmark
University of Aarhus

Completed

Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET

Healthy

Denmark
Hospital de Santa Maria, Portugal
Fundação para a Ciência e a Tecnologia

Completed

Sonographic Evaluation of Fetal Growth in the Third Trimester of Low-risk Pregnancy: a Randomized Trial

Condition of Fetal Growth or Malnutrition (Diagnosis)

Portugal
David Dalessio

Unknown

Effect of GLP-1 on Postprandial Lipid Metabolism

Heart Disease

United States
Papworth Hospital NHS Foundation Trust

Completed

Cardioprotective Effects of GLP-1 and Their Mechanisms

Angina Pectoris

United Kingdom
University Hospital, Gentofte, Copenhagen
Danish Heart Foundation

Completed

Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus

Type 2 Diabetes | Blood Flow | Human Physiology | Glucagon-like Peptide-1 | Blod Pressure

Denmark
Papworth Hospital NHS Foundation Trust

Unknown

GLP-1 Loading During Elective Percutaneous Coronary Intervention (GOLD-PCI)

Myocardial Infarction | Angina Pectoris | Coronary Heart Disease | Reperfusion Injury

United Kingdom
Johns Hopkins University

Terminated

Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery (GLP-1 CABG)

CABG

United States
Xiangya Hospital of Central South University

Recruiting

Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients

Obesity

China
University Hospital, Gentofte, Copenhagen

Completed

The Effect of GLP-1 on the Inhibition of Glucagon Secretion

Type 1 Diabetes | Type 2 Diabetes

Denmark
University of Aarhus

Completed

GLP-1 Infusion and Long-Time Fasting

Type 2 Diabetes

Denmark
University of Arizona
National Heart, Lung, and Blood Institute (NHLBI); Suburban Hospital

Suspended

Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG

Cognitive Impairment | Coronary Artery Bypass Surgery

United States
Instituto de Cardiologia do Rio Grande do Sul

Unknown

Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive Subjects (Ang-(1-7))

Hypertension
Mansoura University

Completed

Long-term Follow-up of Living Liver Donors: A Single-center Experience

Liver Transplantation
University of Copenhagen

Completed

Effects of Intravenous Infusions of Gut Hormones on Appetite and Metabolism. (INGEAR-1)

Obesity

Denmark
University Hospital, Basel, Switzerland

Completed

Oral Administration of Peptides; Absorption From Gastrointestinal Tract

Healthy

Switzerland
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

Bone Cancer | Chondrosarcoma | Recurrent Osteosarcoma | Clear Cell Sarcoma of the Kidney | Metastatic Osteosarcoma | Ovarian Sarcoma | Recurrent Adult Soft Tissue Sarcoma | Recurrent Uterine Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage III Uterine Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Stage...

United States
US Biotest, Inc.
National Institutes of Health (NIH); Integra LifeSciences Corporation

Completed

Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers

Diabetic Foot | Foot Ulcer, Diabetic

United States
Montreal Heart Institute

Completed

Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy (NOVA-SKIN)

Chronic Stable Angina

Canada
University of Pittsburgh
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Comparison Study of PTHrP and PTH to Treat Osteoporosis

Osteoporosis

United States
Amy Arnold
American Heart Association

Recruiting

Angiotensin 1-7 in Obesity Hypertension

Hypertension | Obesity

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II

Acute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Cord Blood Transplant Recipient

United States
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Angiotensin-(1-7) Cardiovascular Effects in Aging

Aging

United States
Amy Arnold

Recruiting

Angiotensin-(1-7) and Energy Expenditure in Human Obesity

Obesity

United States
University of Arizona
United States Department of Defense

Not yet recruiting

Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury (ANGel T)

Traumatic Brain Injury
University of Pittsburgh
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study

Hyperparathyroidism | Osteoporosis | Humoral Hypercalcemia of Malignancy

United States
Rambam Health Care Campus
Constant Therapeutics LLC

Recruiting

Angiotensin 1-7 as a Therapy in the Treatment of COVID-19

COVID-19

Israel
US Biotest, Inc.
Tarix Pharmaceuticals

Terminated

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

HIV Infections

United States
Tarix Pharmaceuticals
Constant Therapeutics LLC

Terminated

Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients (TXA127-PBSC)

Lymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin Disease

United States
Erasme University Hospital
Fonds Erasme pour la Recherche Medicale

Not yet recruiting

Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial (ATCO)

Respiratory Failure | SARS-CoV-2 | Coronavirus | Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere
Erasme University Hospital
Federal University of Minas Gerais; Fonds Erasme pour la Recherche Medicale; ...

Completed

Use of Angiotensin-(1-7) in COVID-19

Respiratory Failure | Infection, Coronavirus

Brazil
Stanford University

Withdrawn

Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients

Covid19

United States
University of Arizona

Suspended

Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients

Cognitive Impairment | Chronic Heart Failure

United States
Tarix Pharmaceuticals

Terminated

Phase I Study Evaluating TXA127 in Low/Intermediate-1 Risk Myelodysplastic Syndrome and Thrombocytopenia

Myelodysplastic Syndrome (MDS)

United States
Ludwig-Maximilians - University of Munich
German Research Foundation; Merck Sharp & Dohme LLC

Completed

Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

Hyperglycemia

Germany
Constant Therapeutics LLC

Recruiting

TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy

DMD-Associated Dilated Cardiomyopathy

Israel
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Columbia University
Constant Therapeutics LLC

Completed

TXA127 for the Treatment of Severe COVID-19

COVID-19

United States
University of Arizona

Not yet recruiting

Biomarker Study: Heart Failure Patients at Risk

Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV

United States
University of Pittsburgh

Withdrawn

One Week Comparison Study of PTH and PTHrP Infusions

Hyperparathyroidism | Osteoporosis | Bone Diseases, Endocrine | Hypercalcemia of Malignancy

United States
Pfizer

Completed

Evaluation of Pharmacokinetic Drug Drug Interaction Between PF-05221304 And PF-06865571 In Healthy Adult Subjects

Healthy

Belgium
Wake Forest University Health Sciences

Completed

FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP) (GAP)

Hypophosphatemia | X-linked Hypophosphatemia | Left Ventricular Hypertrophy | Renin-angiotensin System

United States
Universiti Putra Malaysia

Recruiting

Effect of Core Strength Training on the Physical Fitness and Skills of Youth Field Hockey Players in China

Player

China
Tarix Pharmaceuticals

Completed

Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

Anemia | Thrombocytopenia | Neutropenia | Lymphopenia

United States
Royal Surrey County Hospital NHS Foundation Trust

Completed

Acute Kidney Injury - Biomarkers in Major Abdominal Surgery (AKI-BioMAS)

Acute Kidney Injury

United Kingdom
Kanuni Sultan Suleyman Training and Research Hospital

Completed

Treatment of Angiotensin Peptide (1-7) for COVID-19

COVID-19

Turkey
Sol-Gel Technologies, Ltd.
Accelovance

Completed

Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris

Acne Vulgaris

United States
H. Lundbeck A/S

Completed

Investigating the Absorption, Metabolism and Excretion (AME) of Idalopirdine

Healthy

United Kingdom

Search clinical trials for: GlucagonLikePeptide-1 (7-36)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations